SLC35F2 (solute carrier family 35 member F2)

2018-07-01  

Identity

HGNC
LOCATION
11q22.3
LOCUSID
ALIAS
HSNOV1
FUSION GENES

Other Information

Locus ID:

NCBI: 54733
HGNC: 23615
Ensembl: ENSG00000110660

Variants:

dbSNP: 54733
ClinVar: 54733
TCGA: ENSG00000110660
COSMIC: SLC35F2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000110660ENST00000375682Q8IXU6
ENSG00000110660ENST00000524991E9PKZ2
ENSG00000110660ENST00000525071Q8IXU6
ENSG00000110660ENST00000525815Q8IXU6
ENSG00000110660ENST00000532513E9PJD1
ENSG00000110660ENST00000533664E9PRY2

Expression (GTEx)

0
5
10
15
20
25
30
35

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
377400072023SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53.4
378019872023βTrCP1 promotes SLC35F2 protein ubiquitination and inhibits cancer progression in HeLa cells.0
377400072023SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53.4
378019872023βTrCP1 promotes SLC35F2 protein ubiquitination and inhibits cancer progression in HeLa cells.0
334189442021SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells.7
348157822021USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2.10
334189442021SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells.7
348157822021USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2.10
292741372018Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-β type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis.19
292741372018Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-β type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis.19
218742472011Highly expressed SLC35F2 in non-small cell lung cancer is associated with pathological staging.12
218742472011Highly expressed SLC35F2 in non-small cell lung cancer is associated with pathological staging.12
203796142010Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.78
203796142010Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.78

Citation

Dessen P

SLC35F2 (solute carrier family 35 member F2)

Atlas Genet Cytogenet Oncol Haematol. 2018-07-01

Online version: http://atlasgeneticsoncology.org/gene/57450/slc35f2-(solute-carrier-family-35-member-f2)